menu search

5 low price-to-sales stocks to keep your portfolio in profit

The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, PAM...

June 16, 2023, 9:20 am

Gbpusd wave analysis

GBPUSD broke key resistance level 1.2675 Likely to rise to resistance level 1.2880 GBPUSD currency pair recently broke above the key resistance level ...

June 16, 2023, 3:11 am

3 must-buy stocks on signs of inflation cooling down

The likelihood of a pause in interest rate hikes and weakening inflation bode well for stocks such as Adobe (ADBE), Uber Technologies (UBER) & GIII Ap...

June 14, 2023, 9:26 am

Spx favors rally with bullish momentum & remain supported

Short term, SPX favors upside in wave ((iii)) of 3 started from 4048.28 low of 5.04.2023 and expect to remain supported in pullback. It is nesting as ...

June 14, 2023, 7:16 am

Roche (rhhby) announces positive results from pnh studies

Roche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in the phase...

June 12, 2023, 12:13 pm

Watch these 4 textile - apparel stocks amid industry challenges

The Zacks Textile - Apparel industry participants are grappling with cost inflation and the impacts of reduced discretionary spending. However, store ...

June 12, 2023, 10:28 am

G-iii, pvh, ralph lauren: promising charts even as revenue slows

The American consumer is giving mixed signals when it comes to apparel spending, but clothing companies G-III Apparel Group Ltd. NASDAQ: GIII, PVH Cor...

June 9, 2023, 8:51 am

Fibrogen (fgen) pamrevlumab fails dmd study, stock down 8%

FibroGen???s (FGEN) phase iii study, evaluating pamrevlumab as a combination therapy in certain DMD pat...

June 8, 2023, 2:08 pm

Giii vs. gil: which stock should value investors buy now?

Investors looking for stocks in the Textile - Apparel sector might want to consider either G-III Apparel Group (GIII) or Gildan Activewear (GIL). But ...

June 8, 2023, 12:53 pm

Elliott wave view: gold (xauusd) looking to end wave 5

Cycle from 5.4.2023 high in Gold is in progress as a 5 waves impulse. Down from 5.4.2023 high, wave ((i)) ended at 1999.30 and rally in wave ((ii)) en...

June 8, 2023, 4:42 am

G-iii apparel (giii) q1 earnings beat, sales down y/y

G-III Apparel (GIII) posts better-than-expected earnings results in first-quarter fiscal 2024. The company's digital business also appears encouraging...

June 7, 2023, 3:34 pm

Gsk's rsv vaccine arexvy gets eu approval for older adults

The approval of GSK's RSV vaccine for older adults is based on positive data from the pivotal AReSVi-006 phase...

June 7, 2023, 2:34 pm

Fcm plans for mm-120 (lsd) fda approval in 2026 and extends share lockup until june 15, 2026

FCM Confident in Ability to Start MM-120 Phase iii in 2023 and Obtain FDA Approval In 2026 Dr. Freeman ...

June 7, 2023, 12:07 pm

Lobe sciences appoints baxter phillips iii as chief operating officer

Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has appointed Baxter Phillips iii to the newly create...

June 7, 2023, 8:16 am

G-iii apparel (giii) reports q1 earnings: what key metrics have to say

Although the revenue and EPS for G-III Apparel (GIII) give a sense of how its business performed in the quarter ended April 2023, it might be worth co...

June 6, 2023, 7:31 pm

Spy etf: wave ii pullback found more buyers in blue box

Hello Traders, in this article we will analyze our forecast for SPY ETF in the short term cycle. Since the short term peak of SPY from 05.30.2023 to e...

June 6, 2023, 6:20 pm

Why g-iii apparel stock was climbing today

G-III easily beat expectations thanks to lower inventory from the previous quarter and a much higher gross margin. The company signed a long-term agre...

June 6, 2023, 2:44 pm

Quantum energy to present at ld micro invitational xiii

Presentation on Wed., June 7th at 11 a.m....

June 6, 2023, 2:44 pm

G-iii apparel group (giii) q1 earnings and revenues surpass estimates

G-III Apparel Group (GIII) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. Thi...

June 6, 2023, 9:29 am

Defender pharmaceuticals reports positive results from pivotal phase iii clinical trial of intranasal scopolamine for the prevention of nausea and vomiting induced by motion

ST. LOUIS, June 05, 2023 (GLOBE NEWSWIRE) — Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences com...

June 5, 2023, 1:47 pm


Search within

Pages Search Results: